• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Teladoc Health to Acquire Catapult Health, Advancing Integrated Care Strategy

    2/5/25 7:00:41 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care
    Get the next $TDOC alert in real time by email

    PURCHASE, NY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced that it has signed a definitive agreement to acquire Catapult Health, a leading provider of virtual preventive care services. The company plans to leverage Catapult Health's innovative approach to patient-centric at-home diagnostic testing, as well as its high-touch engagement and clinical support model, to complement Teladoc Health's industry-leading suite of integrated solutions.

    Building on its over 93-million-member base, Teladoc Health's acquisition of Catapult Health supports the company's integrated care segment strategy, discussed most recently during the company's presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The strategy focuses on four key objectives: grow membership and use of services; leverage clinical strength and product breadth to deepen the impact on healthcare outcomes; expand its international business; and advance its scaled mental health position. The Catapult Health acquisition specifically seeks to advance efforts to improve early detection of health conditions, connect Teladoc Health's members with high-quality care and deliver better health outcomes in care management.

    "Catapult Health's capabilities will help advance our strategy in meaningful ways — from giving more members access to convenient and impactful wellness and preventative care, to unlocking greater value for our customers," said Chuck Divita, Chief Executive Officer of Teladoc Health. "Catapult Health brings an experienced team and a strong culture of innovation, and we are thrilled to welcome them to Teladoc Health."

    With Catapult Health's innovative at-home wellness exam, VirtualCheckup, members receive a simple kit with everything they need to collect a blood sample, check blood pressure, and provide other health screening information, followed by a virtual visit with a licensed nurse practitioner to discuss test results, review key health risks, and create a personalized health action plan.

    When Catapult Health's members are assessed with conditions or high-risk factors that require a health action plan, Catapult Health's clinicians will be able to directly enroll eligible members into Teladoc Health's diabetes, hypertension, pre-diabetes and weight management programs, and seamlessly refer them to Teladoc's virtual mental health therapists and primary care providers.

    The company will also use Catapult Health's technology to support new product enhancements, such as providing customers with lab-confirmed A1c values on which to base population enrollment and close gaps in care.

    "For over a decade, we've been helping customers improve health outcomes and bend the cost curve," said David Michel, Chief Executive Officer of Catapult Health. "Joining forces with Teladoc Health will help us accelerate our impact and advance our shared mission to empower healthier lives."

    Key Facts

    Teladoc Health has signed a definitive agreement to acquire Catapult Health in an all-cash transaction for $65 million, with up to $5 million in additional contingent earnout consideration. Catapult Health's trailing twelve-month revenue was approximately $30 million as of the third quarter of 2024. The transaction is expected to close in the first quarter of 2025, subject to customary closing conditions.

    Following the closing of the transaction, Catapult Health will operate within the Integrated Care segment of Teladoc Health.

    With hundreds of employer customers and more than three million covered lives, Catapult Health is recognized for its strong customer satisfaction, clinical outcomes, and cost savings. Catapult Health members consistently praise the VirtualCheckup experience, reflected in an impressive 81+ Net Promoter Score (NPS). The checkup has shown demonstrable results in the early detection of diseases and health risks, with 30% of members discovering high blood pressure and 28% learning they have prediabetes for the first time. Employers and health plans recognize Catapult Health's clinical value, supported by an independent analysis by a third-party health plan confirming that the Catapult Health VirtualCheckup delivers more than $1,400 of cost savings over a 3-year period.

    About Teladoc Health

    Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person's health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com.

    Cautionary Note Regarding Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements include, among others, the potential transaction between Teladoc Health and Catapult, including any statements regarding the expected timetable for completing the potential transaction, the ability to complete the potential transaction, the expected effects of the potential transaction (including projected financial information and future opportunities) and any other statements regarding Teladoc Health's and Catapult's future expectations. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.

    Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, uncertainties as to the timing to consummate the potential transaction; the risk that a condition to closing the potential transaction may not be satisfied; the risk that any regulatory approvals are not obtained or are obtained subject to conditions that are not anticipated by the parties; potential litigation relating to the potential transaction that could be instituted against Teladoc Health, Catapult or their respective directors; the effects of disruption to Teladoc Health's or Catapult's respective businesses; restrictions during the pendency of the potential transaction that may impact Teladoc Health's or Catapult's ability to pursue certain business opportunities or strategic transactions; the effect of this communication on Teladoc Health's stock price; transaction costs; Teladoc Health's ability to achieve the benefits from the proposed transaction; Teladoc Health's ability to effectively integrate acquired operations into its own operations; the ability of Teladoc Health or Catapult to retain and hire key personnel; unknown liabilities; and the diversion of management time on transaction-related issues. Other important factors that could cause actual results to differ materially from those in the forward-looking statements include: (i) changes in laws and regulations applicable to our business model; (ii) changes in market conditions and receptivity to our services and offerings, including our ability to effectively compete; (iii) results of litigation or regulatory actions; (iv) the loss of one or more key clients or the loss of a significant number of members or BetterHelp paying users; (v) changes in valuations or useful lives of our assets; (vi) changes to our abilities to recruit and retain qualified providers into our network; (vii) the impact of and risk related to impairment losses with respect to goodwill or other assets; and (viii) the success of our operational review of the company to achieve a more balanced approach to growth and margin. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports, including, but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the SEC.

    Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

    Media:

    Lou Serio

    [email protected]

    Investors:

    Michael Minchak

    [email protected]

    Photos accompanying this announcement are available at: 

    https://www.globenewswire.com/NewsRoom/AttachmentNg/f3d83c20-3d03-4e73-a1fa-5689b78df61d

    https://www.globenewswire.com/NewsRoom/AttachmentNg/668c1401-5f4b-4b52-a73e-d6e3af303559



    Primary Logo

    Get the next $TDOC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TDOC

    DatePrice TargetRatingAnalyst
    3/10/2026$11.00Hold → Buy
    Deutsche Bank
    2/26/2026$7.00Neutral → Buy
    BofA Securities
    12/9/2025$8.50Equal Weight
    Barclays
    11/13/2025$8.00Market Perform
    BMO Capital Markets
    7/25/2025$10.00Neutral
    Mizuho
    11/15/2024$14.00Buy
    Goldman
    9/17/2024$8.00 → $10.00Hold
    Jefferies
    2/29/2024$22.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $TDOC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Paulus Kenneth H bought $69,400 worth of shares (10,000 units at $6.94) (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    11/17/25 4:05:05 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Director Mckinley Thomas bought $30,756 worth of shares (4,000 units at $7.69), increasing direct ownership by 11% to 39,077 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    9/13/24 5:14:02 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Director Smith Mark Douglas bought $28,312 worth of shares (4,000 units at $7.08), increasing direct ownership by 92% to 8,355 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    8/19/24 4:10:41 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

    NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective March 1, 2026, in connection with commencing employment as Chief Growth Officer, U.S. Group Health, Daniel Conroy was granted an award of restricted stock units covering 57,034 shares of Teladoc Health's common stock, par value $0.001 per share ("Common Stock"), and an award of performance stock units covering a target of 57,034 shares of Common Stock (for which up to 114,068 shares may be earned). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the

    3/4/26 4:05:00 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health to Participate in Upcoming Investor Conference

    NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the Barclays 28th Annual Global Healthcare Conference in Miami on March 10th, 2026, at 1:00 p.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/.  About Teladoc Health Teladoc Health (NYSE:TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health

    3/3/26 4:05:00 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

    NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today reported financial results for the three months ended December 31, 2025 ("Fourth Quarter 2025") and full year ended December 31, 2025 ("Full Year 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended December 31, 2024 ("Fourth Quarter 2024") and full year ended December 31, 2024 ("Full Year 2024"). Highlights Fourth Quarter 2025 revenue of $642.3 million, flat year-over-year, and Full Year 2025 revenue of $2,530.0 million, down 2% year-over-yearFourth Quarter 2025 net loss of $25.1 million, or $0.14 per share, and Full Year 2

    2/25/26 4:05:00 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Teladoc upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Teladoc from Hold to Buy and set a new price target of $11.00

    3/10/26 8:39:03 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc upgraded by BofA Securities with a new price target

    BofA Securities upgraded Teladoc from Neutral to Buy and set a new price target of $7.00

    2/26/26 12:11:08 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Barclays initiated coverage on Teladoc with a new price target

    Barclays initiated coverage of Teladoc with a rating of Equal Weight and set a new price target of $8.50

    12/9/25 8:53:51 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    SEC Filings

    View All

    SEC Form 144 filed by Teladoc Health Inc.

    144 - Teladoc Health, Inc. (0001477449) (Subject)

    3/11/26 3:35:25 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    SEC Form 144 filed by Teladoc Health Inc.

    144 - Teladoc Health, Inc. (0001477449) (Subject)

    3/2/26 5:10:01 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    SEC Form 144 filed by Teladoc Health Inc.

    144 - Teladoc Health, Inc. (0001477449) (Subject)

    3/2/26 4:57:09 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by President, U.S. Group Health Bliss Kelly

    4/A - Teladoc Health, Inc. (0001477449) (Issuer)

    3/12/26 4:06:42 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    CHIEF EXECUTIVE OFFICER Divita Charles Iii converted options into 64,653 shares and sold $152,243 worth of shares (27,731 units at $5.49), increasing direct ownership by 11% to 364,784 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    3/12/26 4:06:12 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Chief Accounting Officer Catapano Joseph Ronald converted options into 3,488 shares and sold $6,821 worth of shares (1,333 units at $5.12), increasing direct ownership by 32% to 8,841 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    3/3/26 4:09:03 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Leadership Updates

    Live Leadership Updates

    View All

    AR/VR is Revolutionizing Medical Education & Training While Transforming Healthcare Industry

    NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- MarketNewsUpdates News Commentary A recent report from ResearchAndMarkets said that the U.S. augmented reality and virtual reality in healthcare market size which was estimated at USD 1.03 billion in 2024 is projected to grow at a CAGR of 15.4% from 2025 to 2030. It said that advancements in healthcare IT infrastructure and increased venture capital investment, fueled by numerous start-ups and government programs such as NIH and FDA initiatives, support AR/VR research. In addition, the declining cost of head-mounted devices, rising demand from telemedicine, chronic disease care, and minimally invasive surgery, and integration with AI and 5G tech

    10/28/25 9:00:00 AM ET
    $GPRO
    $QCOM
    $TDOC
    Industrial Machinery/Components
    Consumer Discretionary
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Teladoc Health Board of Directors Announces Leadership Transition

    Jason Gorevic to depart the company, effective immediatelyCFO Mala Murthy appointed acting chief executiveTeladoc Health reaffirms guidance PURCHASE, NY, April 05, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that Jason Gorevic is departing the company, effective immediately. The Board of Directors has appointed Mala Murthy acting Chief Executive Officer while it searches for Mr. Gorevic's permanent successor. Ms. Murthy is a seasoned industry leader who has served as the Company's Chief Financial Officer since 2019, and she will continue serving in this role during this transition period. The Board has ret

    4/5/24 6:30:18 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

    PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,

    9/20/23 8:05:00 AM ET
    $SGRY
    $TDOC
    Hospital/Nursing Management
    Health Care
    Medical/Nursing Services

    $TDOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Teladoc Health Inc.

    SC 13G - Teladoc Health, Inc. (0001477449) (Subject)

    9/5/24 4:36:22 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Teladoc Health Inc.

    SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

    7/8/24 4:32:41 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Teladoc Health Inc. (Amendment)

    SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

    2/13/24 5:16:08 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Financials

    Live finance-specific insights

    View All

    Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

    NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today reported financial results for the three months ended December 31, 2025 ("Fourth Quarter 2025") and full year ended December 31, 2025 ("Full Year 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended December 31, 2024 ("Fourth Quarter 2024") and full year ended December 31, 2024 ("Full Year 2024"). Highlights Fourth Quarter 2025 revenue of $642.3 million, flat year-over-year, and Full Year 2025 revenue of $2,530.0 million, down 2% year-over-yearFourth Quarter 2025 net loss of $25.1 million, or $0.14 per share, and Full Year 2

    2/25/26 4:05:00 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health Appoints Michael Smith, Experienced Insurance and Financial Services Executive, to Its Board of Directors

    NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced the appointment of Michael Smith to its board of directors. With more than three decades of leadership experience in financial management and strategic transformation, Mr. Smith brings a deep understanding of long-term business sustainability within highly regulated, global markets. He joins the board following the previously announced retirements of Eric Evans and Thomas McKinley and will serve on the board's audit and nominating and corporate governance committees. "Michael's experience leading enterprise transformations makes him a strong addition to the Board," sa

    2/18/26 4:30:00 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health to Announce Fourth Quarter 2025 Financial Results

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release fourth quarter 2025 results on Wednesday, February 25, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 330912. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=95347. A live audio webcast will also be available online at https:/

    2/5/26 4:30:00 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care